Quinn Opportunity Partners’s Medtronic MDT Stock Holding History

Quinn Opportunity Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,500	Closed	-$720K	–	399
2025 Q4	$720K	Sell	7,500 -10,500	-58%	-$1.02M	0.03%	251
2025 Q3	$1.71M	Hold	18,000	–	–	0.12%	152
2025 Q2	$1.57M	Hold	18,000	–	–	0.13%	151
2025 Q1	$1.62M	Sell	18,000 -22,100	-55%	-$1.98M	0.11%	181
2024 Q4	$3.2M	Hold	40,100	–	–	0.22%	114
2024 Q3	$3.61M	Hold	40,100	–	–	0.35%	69
2024 Q2	$3.16M	Hold	40,100	–	–	0.36%	69
2024 Q1	$3.49M	Buy	+40,100	New	+$3.42M	0.39%	68
2017 Q4	–	Sell	-3,000	Closed	-$233K	–	202
2017 Q3	$233K	Sell	3,000 -2,000	-40%	-$166K	0.04%	185
2017 Q2	$444K	Sell	5,000 -2,300	-32%	-$194K	0.07%	120
2017 Q1	$588K	Hold	7,300	–	–	0.14%	105
2016 Q4	$520K	Buy	+7,300	New	+$574K	0.16%	105
2016 Q2	–	Sell	-6,200	Closed	-$465K	–	118
2016 Q1	$465K	Buy	+6,200	New	+$467K	0.18%	75
2015 Q3	–	Sell	-21,000	Closed	-$1.56M	–	123
2015 Q2	$1.56M	Sell	21,000 -4,214	-17%	-$322K	0.74%	37
2015 Q1	$1.97M	Buy	+25,214	New	+$1.91M	1.05%	28

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quinn Opportunity Partners's MDT Position: Q1 2026 in Review

Quinn Opportunity Partners sold out of Medtronic (MDT) in Q1 2026, closing a stake of 7,500 shares — an estimated $720K sold.

Quinn Opportunity Partners first reported a position in MDT in Q1 2015 and held it in 15 quarters. The position peaked at $3.61M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Quinn Opportunity Partners reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Quinn Opportunity Partners sold 7,500 Medtronic shares in Q1 2026, an estimated $720K.
Quinn Opportunity Partners first reported a position in Medtronic in Q1 2015 and held it in 15 quarters.
Quinn Opportunity Partners's Medtronic position peaked at $3.61M in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.